The facial injectable market size is USD 15.3 Bn in 2026.
The facial injectable market is projected to grow at a CAGR of 6% by 2033.
The facial injectable market growth drivers include rising aesthetic procedures, increasing male participation, and growing awareness through social media.
North America is a dominating region for the facial injectable market.
AbbVie Inc. (Allergan Aesthetics), Galderma S.A., Merz Pharma GmbH & Co. KGaA, Ipsen S.A., and Hugel, Inc. are some leading industry players in the facial injectable market.